右侧和左侧结直肠癌的多维差异及其对向治疗的影响
Marwa Abdel Hamid1, Lorenz M Pammer2, Silvia Oberparleiter3
1Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.
NPJ precision oncology
|April 22, 2025
概括
由于生物差异,右侧结直肠癌 (RCRC) 的预后比左侧结直肠癌 (LCRC) 更差. 整合分子洞察力可能会改进治疗方法并改善转移性结直肠癌 (mCRC) 的结果.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 遗传学 遗传学 是一个
背景情况:
- 转移性结直肠癌 (mCRC) 的存活率仍然很差,右侧CRC (RCRC) 的预后比左侧CRC (LCRC) 更差.
- 这种差异归因于RCRC和LCRC之间的显著生物和分子差异.
研究的目的:
- 对RCRC和LCRC之间的区别进行全面的文献审查.
- 探索胚胎学,解剖学,病理学,奥米克和瘤微环境 (TME) 如何影响预后和治疗反应.
- 检查治疗影响,并考虑完善CRC的二进制分类.
主要方法:
- 对比RCRC和LCRC的研究的文献综述.
- 分析胚胎学,解剖学,病理学,体质学和TME方面的差异.
- 评估当前和潜在的未来治疗策略.
主要成果:
- RCRC和LCRC表现出不同的临床表现,结果和分子/遗传特征.
- 胚胎学,解剖学,病理学,体质学和TME的差异导致不同的预后和治疗反应.
- 当前的二进制分类可能过于简化了生物复杂性.
结论:
- RCRC和LCRC的独特生物特征需要更深入的理解,而不仅仅是简单的右/左二分法.
- 未来的个性化治疗策略,特别是mCRC中的抗EGFR疗法,应该整合分子数据.
- 根据分子见解改进CRC分类对于改善患者的治疗结果至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K